Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1 2 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 24 Neoplasms 15 Prostatic Neoplasms 12 Lung Neoplasms 11 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Head and Neck Neoplasms 5 Stomach Neoplasms 4 Rectal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Basal Cell 4 Uterine Cervical Dysplasia 3 Skin Neoplasms 3 Melanoma 3 Glioma 3 Glioblastoma 3 Esophageal Neoplasms 3 Disease 3 Colorectal Neoplasms 3 Central Nervous System Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Breast Carcinoma In Situ 3 Barrett Esophagus 3 Thyroid Neoplasms 2 Sarcoma 2 Precancerous Conditions 2 Oligodendroglioma 2

Interventions

Radiotherapy 10 fludarabine phosphate 9 Peripheral Blood Stem Cell Transplantation 8 Cyclosporine 7 Cyclophosphamide 7 Busulfan 7 Whole-Body Irradiation 6 Melphalan 6 Radiofrequency Ablation 5 Mycophenolic Acid 5 Filgrastim 5 Antilymphocyte Serum 5 Surveys and Questionnaires 4 Surgical Procedures, Operative 4 Methotrexate 4 Etoposide 4 Drug Therapy 4 Cisplatin 4 fludarabine 3 Radiosurgery 3 Injections 3 Hepatectomy 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 lenvatinib 2 Vinblastine 2 Videotape Recording 2 Thiotepa 2 Standard of Care 2 Sorafenib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Recurrence × Biopsy × Clear all

NCT02613962 2026-04-01

MAPPYACTS

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Completed

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡